Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:
You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist.
Please log in to your account or sign up in order to add this asset to your watchlist.
MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.
DENTSPLY SIRONA has received a consensus rating of Hold. The company's average rating score is 2.22, and is based on 3 buy ratings, 5 hold ratings, and 1 sell rating.
According to analysts' consensus price target of $48.11, DENTSPLY SIRONA has a forecasted upside of 28.0% from its current price of $37.58.
DENTSPLY SIRONA has only been the subject of 4 research reports in the past 90 days.
DENTSPLY SIRONA pays a meaningful dividend of 1.35%, higher than the bottom 25% of all stocks that pay dividends.
DENTSPLY SIRONA has been increasing its dividend for 12 years.
The dividend payout ratio of DENTSPLY SIRONA is 29.59%. This payout ratio is at a healthy, sustainable level, below 75%.
Based on earnings estimates, DENTSPLY SIRONA will have a dividend payout ratio of 18.94% next year. This indicates that DENTSPLY SIRONA will be able to sustain or increase its dividend.
In the past three months, DENTSPLY SIRONA insiders have not sold or bought any company stock.
Only 0.76% of the stock of DENTSPLY SIRONA is held by insiders.
94.79% of the stock of DENTSPLY SIRONA is held by institutions. High institutional ownership can be a signal of strong market trust in this company.
Earnings for DENTSPLY SIRONA are expected to grow by 10.46% in the coming year, from $2.39 to $2.64 per share.
The P/E ratio of DENTSPLY SIRONA is 22.24, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 133.46.
The P/E ratio of DENTSPLY SIRONA is 22.24, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 96.44.
DENTSPLY SIRONA has a PEG Ratio of 3.00. PEG Ratios above 1 indicate that a company could be overvalued.
DENTSPLY SIRONA has a P/B Ratio of 1.63. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.
DENTSPLY SIRONA Inc. designs, develops, manufactures, distributes, and sells various dental products and technologies for professional dental market worldwide. It offers dental equipment, including treatment centers, imaging equipment, motorized dental handpieces, and other instruments; imaging equipment; treatment centers comprising basic dentist chairs, sophisticated chair-based units with integrated diagnostic, hygiene and ergonomic functionalities, and specialist centers; and lab equipment, such as amalgamators, mixing machines, and porcelain furnaces. The company also provides dental CAD/CAM products, digital impressions intraoral scanners, mills, and services; and orthodontic products, including high frequency vibration technology device under the name VPro, dentist-directed clear aligner solutions under the name SureSmile, and direct-to-consumer clear aligner solutions under the name Byte; dental implant products, bone regenerative and restorative solutions, and educational programs; and urology catheters and other healthcare-related consumable products. In addition, it offers endodontic products comprising endodontic instruments and materials, drills, filers, sealers, irrigation needles, and other tools or single-use solutions; restorative products that include dental prosthetics, such as artificial teeth, dental ceramics, digital dentures, precious metal dental alloys, and crown and bridge porcelain products; small equipment products comprise intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers; and dental supplies, including dental anesthetics, prophylaxis paste, dental sealants, impression materials, teeth whiteners, and topical fluoride. The company was formerly known as DENTSPLY International Inc. and changed its name to DENTSPLY SIRONA Inc. in February 2016. DENTSPLY SIRONA Inc. was founded in 1899 and is headquartered in Charlotte, North Carolina.
Shares of DENTSPLY SIRONA stock traded up $0.06 during trading hours on Friday, hitting $37.23. 225 shares of the company were exchanged, compared to its average volume of 1,586,766. DENTSPLY SIRONA has a 1 year low of $33.78 and a 1 year high of $63.10. The company has a current ratio of 1.45, a quick ratio of 1.03 and a debt-to-equity ratio of 0.38. The business has a 50-day moving average of $36.31 and a 200-day moving average of $43.50. The stock has a market capitalization of $8.02 billion, a price-to-earnings ratio of 21.99, a P/E/G ratio of 3.00 and a beta of 0.91.
DENTSPLY SIRONA (NASDAQ:XRAY - Get Rating) last released its quarterly earnings results on Tuesday, May 10th. The medical instruments supplier reported $0.52 EPS for the quarter, topping the consensus estimate of $0.50 by $0.02. The business had revenue of $9.67 billion during the quarter, compared to analysts' expectations of $982.05 million. DENTSPLY SIRONA had a return on equity of 11.63% and a net margin of 8.81%. The company's quarterly revenue was up 841.1% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.72 earnings per share. As a group, analysts expect that DENTSPLY SIRONA will post 2.39 EPS for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 14th. Shareholders of record on Friday, September 30th will be given a $0.125 dividend. This represents a $0.50 annualized dividend and a yield of 1.34%. The ex-dividend date is Thursday, September 29th. DENTSPLY SIRONA's payout ratio is 29.59%.
Several equities analysts have weighed in on XRAY shares. William Blair downgraded DENTSPLY SIRONA from a "market perform" rating to an "underperform" rating in a research report on Friday, August 5th. Robert W. Baird downgraded DENTSPLY SIRONA from an "outperform" rating to a "neutral" rating and lowered their price objective for the stock from $67.00 to $48.00 in a research report on Tuesday, April 19th. The Goldman Sachs Group lowered their price objective on DENTSPLY SIRONA from $42.00 to $41.00 and set a "neutral" rating for the company in a research report on Thursday, July 21st. Piper Sandler lowered their price target on DENTSPLY SIRONA from $41.00 to $38.00 in a report on Monday, July 11th. Finally, Barrington Research lowered their price target on DENTSPLY SIRONA from $53.00 to $51.00 in a report on Wednesday, May 11th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and four have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Hold" and a consensus price target of $48.11.
Sign-up to receive the latest news and ratings for DENTSPLY SIRONA and its competitors with MarketBeat's FREE daily newsletter.
Sign-up to receive the latest news and ratings for DENTSPLY SIRONA and its competitors with MarketBeat's FREE daily newsletter.
9 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for DENTSPLY SIRONA in the last twelve months. There are currently 1 sell rating, 5 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" XRAY shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in XRAY, but not buy additional shares or sell existing shares. View XRAY analyst ratings or view top-rated stocks.
9 brokers have issued 1-year target prices for DENTSPLY SIRONA's stock. Their XRAY share price forecasts range from $38.00 to $67.00. On average, they expect the company's stock price to reach $48.11 in the next year. This suggests a possible upside of 28.1% from the stock's current price. View analysts price targets for XRAY or view top-rated stocks among Wall Street analysts.
DENTSPLY SIRONA's stock was trading at $55.79 at the beginning of 2022. Since then, XRAY shares have decreased by 32.7% and is now trading at $37.57. View the best growth stocks for 2022 here.
The company is scheduled to release its next quarterly earnings announcement on Thursday, August 18th 2022. View our XRAY earnings forecast.
DENTSPLY SIRONA Inc. (NASDAQ:XRAY) announced its quarterly earnings results on Thursday, November, 4th. The medical instruments supplier reported $0.68 earnings per share for the quarter, beating analysts' consensus estimates of $0.65 by $0.03. The medical instruments supplier had revenue of $1.07 billion for the quarter, compared to analyst estimates of $1.02 billion. DENTSPLY SIRONA had a trailing twelve-month return on equity of 11.63% and a net margin of 8.81%. DENTSPLY SIRONA's quarterly revenue was up 19.4% compared to the same quarter last year. During the same quarter last year, the company earned $0.67 earnings per share. Read the conference call transcript.
DENTSPLY SIRONA declared a quarterly dividend on Thursday, August 4th. Investors of record on Friday, September 30th will be paid a dividend of $0.125 per share on Friday, October 14th. This represents a $0.50 annualized dividend and a yield of 1.33%. The ex-dividend date of this dividend is Thursday, September 29th. Read our dividend analysis for XRAY.
DENTSPLY SIRONA (NASDAQ:XRAY) pays an annual dividend of $0.50 per share and currently has a dividend yield of 1.35%. The company has been increasing its dividend for 12 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 29.59%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, XRAY will have a dividend payout ratio of 18.94% next year. This indicates that the company will be able to sustain or increase its dividend. Read our dividend analysis for XRAY.
DENTSPLY SIRONA updated its FY 2022 earnings guidance on Tuesday, June, 7th. The company provided EPS guidance of $2.35-$2.55 for the period, compared to the consensus estimate of $2.77. The company issued revenue guidance of $4.10 billion-$4.20 billion, compared to the consensus revenue estimate of $4.23 billion.
105 employees have rated DENTSPLY SIRONA Chief Executive Officer Don Casey on Glassdoor.com. Don Casey has an approval rating of 70% among the company's employees.
Based on aggregate information from My MarketBeat watchlists, some companies that other DENTSPLY SIRONA investors own include NVIDIA (NVDA), Intel (INTC), QUALCOMM (QCOM), Boeing (BA), General Electric (GE), International Business Machines (IBM), Broadcom (AVGO), Comcast (CMCSA), Gilead Sciences (GILD) and Tesla (TSLA).
DENTSPLY SIRONA trades on the NASDAQ under the ticker symbol "XRAY."
DENTSPLY SIRONA's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Artisan Partners Limited Partnership (5.92%), Nuance Investments LLC (4.20%), Cooke & Bieler LP (2.19%), Mackenzie Financial Corp (1.90%), Lazard Asset Management LLC (0.60%) and Deutsche Bank AG (0.42%). Insiders that own company stock include Donald M Jr Casey, Eric Brandt, Gregory T Lucier, Lisa Yankie, Michael C Alfano, Walter Petersohn, William E Newell and Willie A Deese. View institutional ownership trends.
Shares of XRAY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here.
One share of XRAY stock can currently be purchased for approximately $37.57.
DENTSPLY SIRONA (NASDAQ:XRAY) has a market capitalization of $8.09 billion and generates $4.25 billion in revenue each year. The medical instruments supplier earns $421 million in net income (profit) each year or $1.69 on an earnings per share basis.
The company employs 15,000 workers across the globe.
DENTSPLY SIRONA was founded in 2016.
DENTSPLY SIRONA's mailing address is 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC, 28277. The official website for the company is www.dentsplysirona.com. The medical instruments supplier can be reached via phone at (844) 848-0137, via email at john.sweeney@dentsplysirona.com, or via fax at 302-655-5049.
Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.
MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.
Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.
Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.
MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.
Twitter Facebook StockTwits Financial Juice YouTube
© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved. 326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257 MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds
© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.